Capricor Therapeutics (CAPR) EBIT (2010 - 2026)
Capricor Therapeutics' (CAPR) quarterly EBIT came in at -$36.8 million in Q1 2026, down 47.19% year-on-year from -$69.6 million in Q1 2025, and down 26.12% quarter-over-quarter from -$29.2 million in Q4 2025.
Capricor Therapeutics (CAPR) EBIT (2010 - 2026) Analysis & Trends
Capricor Therapeutics' EBIT history runs 17 years deep, the most recent figure standing at -$36.8 million for Q1 2026.
- On a quarterly basis, EBIT fell 47.19% year-over-year to -$36.8 million in Q1 2026; TTM through Mar 2026 was -$119.9 million, a 109.38% decrease from a year earlier, with the FY2025 full-year figure at -$108.1 million, down 154.07% from the prior year.
- EBIT slipped to -$36.8 million in Q1 2026 per CAPR's latest filing, from -$29.2 million in the prior quarter.
- Across five years, EBIT topped out at -$1.3 million in Q4 2023 and bottomed at -$36.8 million in Q1 2026.
- The 5-year median for EBIT is -$8.2 million (2023), against an average of -$14.2 million.
- Across the five-year window, EBIT surged 84.12% in 2023 and sank 500.66% in 2024, its largest moves.
- Year by year, EBIT stood at -$8.1 million in 2022, then jumped by 84.12% to -$1.3 million in 2023, then sank by 500.66% to -$7.7 million in 2024, then slumped by 278.83% to -$29.2 million in 2025, then declined by 26.12% to -$36.8 million in 2026.
- Per Business Quant, the three latest CAPR EBIT figures stand at -$36.8 million (Q1 2026), -$29.2 million (Q4 2025), and -$26.3 million (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -15.76 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 249.90 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 394.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -445.22 Mn |
| 10 | Capricor Therapeutics | 1.12 Bn | 1.12 Bn | - | -36.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -36.77 Mn |
| Dec 31, 2025 | -29.16 Mn |
| Sep 30, 2025 | -26.28 Mn |
| Jun 30, 2025 | -27.72 Mn |
| Mar 31, 2025 | -24.98 Mn |
| Dec 31, 2024 | -7.70 Mn |
| Sep 30, 2024 | -13.01 Mn |
| Jun 30, 2024 | -11.59 Mn |
| Mar 31, 2024 | -10.27 Mn |
| Dec 31, 2023 | -1.28 Mn |
| Sep 30, 2023 | -6.86 Mn |
| Jun 30, 2023 | -7.75 Mn |
| Mar 31, 2023 | -8.18 Mn |
| Dec 31, 2022 | -8.07 Mn |
| Sep 30, 2022 | -6.48 Mn |
| Jun 30, 2022 | -7.32 Mn |
| Mar 31, 2022 | -7.83 Mn |
| Dec 31, 2021 | -6.38 Mn |
| Sep 30, 2021 | -4.31 Mn |
| Jun 30, 2021 | -5.08 Mn |